Successful treatment of malignant pericardial effusion, using weekly paclitaxel, in a patient with breast cancer

International Journal of Clinical Oncology

Volumn 11, Issue 5, 2006, Pages 412-415

  Einama, Takahiro ^a   Sato, Kazuhiko ^a   Tsuda, Hitoshi ^a   Mochizuki, Hidetaka ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Breast cancer; Clinicopharmacological study; Pericardial effusion; Tamponade; Weekly paclitaxel

Indexed keywords

ANTHRACYCLINE; DEXAMETHASONE; DIPHENHYDRAMINE; GOSERELIN; PACLITAXEL; RANITIDINE; TAMOXIFEN;

ADULT; ARTICLE; BREAST CANCER; CASE REPORT; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG TRANSPORT; FEMALE; FOLLOW UP; HEART TAMPONADE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOSPITAL READMISSION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MASTECTOMY; PERICARDIAL EFFUSION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARDIAC TAMPONADE; DRAINAGE; FATAL OUTCOME; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PACLITAXEL; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; TREATMENT OUTCOME;

EID: 33750295149     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-006-0593-2     Document Type: Article

References (23)

1. GR Corey PT Campbell P Van Trigt 1993 Etiology of large pericardial effusions Am J Med 95 209 213
2. RS Fraser JB Viloria NS Wang 1980 Cardiac tamponade as a presentation of extracardiac malignancy Cancer 45 1697 1704
3. JD Bitran R Evans C Brown 1984 The management of cardiac tamponade in patients with breast cancer J Surg Oncol 27 42 44
4. EA Perez 1998 Paclitaxel in breast cancer Oncologist 3 373 389
5. AD Seidman D Berry C Cirrincione 2004 CALGB 9840: Phase III study of weekly paclitaxel via 1-h infusion vs standard 3-h infusion every third week in the treament of metastatic breast cancer, with trastuzumab for HER2+ metastatic breast cancer (MBC), and randomized for trastuzumab for HER2 normal MBC Proc Am Soc Clin Oncol 22 512
6. HJ Luck H Roche 2002 Weekly paclitaxel: an effective and well-tolerated treatment in patients with advanced breast cancer Crit Rev Oncol Hematol 44 15 30
7. K Sato K Inoue T Saito 2003 Multicenter phase trial of weekly paclitaxel for advanced or metastatic breast cancer: the Saitama Breast Cancer Clinical Study Group (SBCCSG-01) Jpn J Clin Oncol 33 371 376
8. International Union Aganinst Cancer (UICC) 2002 Breast tumors TNM classification of malignancy tumors 6th edn Wiley-Liss New York 131 141
9. JL Grem KD Tutsch KJ Simon 1987 Phase I study of taxol administered as a short i.v. infusion daily for 5 days Cancer Treat Rep 71 1179 1184
10. YF Chang LL Li CW Wu 1996 Paclitaxel-induced apoptosis in human gastric carcinoma cell lines Cancer 77 14 18
11. H Theologides 1978 Neoplastic cardiac tamponade Semin Oncol 5 181 190
12. W Markiewicz R Borovik S Ecker 1986 Cardiac tamponade in medical patients: treatment and prognosis in the echocardiographic era Am Heart J 111 1138 1142
13. PT Vaitkus HC Herrmann MM LeWinter 1994 Treatment of malignant pericardial effusion JAMA 272 59 64
14. JD Wilkes P Fidias L Vaickus 1995 Malignancy-related pericardial effusion. 127 cases from the Roswell Park Cancer Institute Cancer 76 1377 1387
15. RJ Laham DJ Cohen RE Kuntz 1996 Pericardial effusion in patients with cancer: outcome with contemporary management strategies Heart 75 67 71
16. FE Smith M Lane P Hudgins 1974 Conservative management of pericardial effusion Cancer 33 45 57
17. JG Krikorian EW Hancock 1978 Pericardiocentesis Am J Med 65 808 814
18. EP Flannery G Gregoratos MP Corder 1975 Pericardial effusions in patients with malignant diseases Arch Intern Med 135 976 977
19. KE Alcan PM Zabetakis ND Marino 1982 Management of acute cardiac tamponade by subxiphoid pericardiotomy JAMA 247 1143 1148
20. JS Park R Rentschler D Wilbur 1991 Surgical management of pericardial effusion in patients with malignancies. Comparison of subxiphoid window versus pericardiectomy Cancer 67 76 80
21. EP Winer DA Berry S Woolf 2004 Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: Cancer and Leukemia Group B trial 9342 J Clin Oncol 22 2061 2068
22. T Ohtsu Y Sasaki T Tamura 1995 Clinical pharmacokinetics and pharmacodynamics of paclitaxel: a 3-hour infusion versus a 24-hour infusion Clin Cancer Res 1 599 606
23. S Urabe H Fujiwara M Egawa 2004 Recurrent ovarian cancer with cancer peritonitis treated with weekly paclitaxel infusion-a clinicopharmacological study (in Japanese) Jpn J Cancer Chemother 31 449 451